Elisa Oyj (ELMUY)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

31.44

0.00

(0.00%)

At close: 03:00PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	31.44
Open	31.44
Bid	N/A x N/A
Ask	N/A x N/A
Day's Range	31.44 - 31.44
52 Week Range	25.45 - 32.00
Volume	20
Avg. Volume	708

Market Cap	10.387B
Beta (5Y Monthly)	-0.01
PE Ratio (TTM)	26.80
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ELMUY

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

ELISA OYJ UNSP ADR EACH REPR 0.
Analyst Report: MERCK Kommanditgesellschaft auf AktienMerck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (46% of 2021 sales) provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (36%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Rating
Fair Value
Economic Moat
10 days agoMorningstar